Evaluating bioequivalence of meloxicam tablets: is in-vitro dissolution test overdiscriminating?
Journal of Pharmacy and Pharmacology2017Vol. 70(2), pp. 250–258
Citations Over Time
Abstract
Comparative dissolution profiles using similarity factor (f2 ) in the recommended media should be relaxed to fulfil the requirements for the development, scale-up and postapproval changes to immediate release oral solid dosage forms of meloxicam.
Related Papers
- → A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability(1995)5,268 cited
- → Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model(2018)20 cited
- → An Investigation into the Influence of Experimental Conditions on In Vitro Drug Release from Immediate-Release Tablets of Levothyroxine Sodium and Its Relation to Oral Bioavailability(2011)18 cited
- → Development of a Dissolution Test for Extended-Release Bromopride Pellets with In Vivo–In Vitro Correlation(2015)10 cited
- Razvoj biorelevantne metode ispitivanja in vitro oslobađanja metaksalona iz tableta trenutnog oslobađanja(2019)